(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

B Braun 3125-11 - 2g Cefoxitin for Injection with Dextrose Injection, 50mL, 24/CS

B Braun # 3125-11 - 2g Cefoxitin for Injection with Dextrose Injection, 50mL, 24/CS
Part Number B Braun 3125-11
SKU Number CIA8038123
Sell Unit CASE
Ships Within Special Order
List Price $1,200.26
Enter a valid quantity
Product Description

B Braun 3125-11 - 2g Cefoxitin for Injection with Dextrose Injection, 50mL, 24/CS

The B Braun 3125-11 combines 2g of Cefoxitin, a broad-spectrum second-generation cephalosporin antibiotic, with 50mL of Dextrose Injection in a ready-to-use formulation for intravenous (IV) therapy. This pre-mixed solution ensures precise dosing and ease of use, minimizing preparation time and reducing the risk of medication errors.

Manufactured to meet USP standards, this sterile, single-dose product is designed to treat a variety of bacterial infections in clinical environments such as hospitals, surgical centers, and outpatient care facilities.

Key Features and Benefits

  • 2g Cefoxitin (Second-Generation Cephalosporin):
    Effective against a broad range of Gram-positive and Gram-negative bacteria, including anaerobic pathogens.

  • 50mL Dextrose Injection:
    Serves as a carrier solution for IV administration, ensuring proper dilution and delivery.

  • Pre-Mixed and Ready-to-Use:
    Reduces preparation time, improves workflow efficiency, and minimizes the risk of dosing errors.

  • Sterile and Non-Pyrogenic:
    Ensures contamination-free administration, adhering to stringent safety standards.

  • Latex-Free Construction:
    Safe for patients with latex sensitivities, enhancing compatibility.

Indications

This medication is commonly prescribed for:

  • Intra-Abdominal Infections: Such as peritonitis or diverticulitis caused by susceptible bacteria.
  • Gynecological Infections: Including endometritis and pelvic inflammatory disease.
  • Bone and Joint Infections: Treating osteomyelitis and septic arthritis.
  • Respiratory Tract Infections: Addressing bacterial pneumonia and bronchitis.
  • Sepsis and Bloodstream Infections: Combatting systemic bacterial infections.

Consult a healthcare professional for specific treatment guidelines and dosing recommendations.

Compatibility and Applications

The Cefoxitin and Dextrose Injection is compatible with standard IV administration systems and is suitable for:

  • Hospital Settings: Providing effective IV antibiotic therapy for severe bacterial infections.
  • Emergency Medicine: Supporting timely intervention for critical bacterial infections.
  • Outpatient Infusion Therapy: Enabling continued care for patients requiring IV antibiotics.

Usage Guidelines

  1. Pre-Use Inspection: Ensure the packaging is intact and the solution is sterile before use.
  2. Connection: Attach to a compatible IV administration set using aseptic techniques.
  3. Administration: Administer the medication as directed by a healthcare provider, monitoring the patients response.
  4. Disposal: Dispose of the container responsibly after single use, adhering to institutional waste management protocols.

For detailed instructions, refer to the product label and prescribing information.

Certifications, Safety Standards, and Regulatory Approvals

The B Braun 3125-11 Cefoxitin and Dextrose Injection complies with:

  • FDA Approval: Certifying its safety and efficacy for treating bacterial infections.
  • USP Standards: Ensuring high purity, consistent quality, and reliable performance.
  • ISO Certification: Meeting international standards for sterile medical products.

These certifications validate the products safety and effectiveness for clinical use.

Comparison with Competitor Products

The B Braun Cefoxitin and Dextrose Injection offers key advantages:

  • Ready-to-Use Formulation: Reduces preparation time and minimizes the risk of contamination compared to vials requiring reconstitution.
  • Broad-Spectrum Coverage: Effective against a wide variety of bacteria, including anaerobes, making it versatile for diverse infections.
  • Trusted Brand: Backed by B Brauns legacy of innovative and reliable medical solutions.

Typical User Profile and Application Scenarios

This product is designed for:

  • Healthcare Providers: Administering effective antibiotic therapy in hospitals and clinics.
  • Emergency Care Teams: Delivering rapid treatment for severe bacterial infections.
  • Outpatient Infusion Specialists: Supporting IV antibiotic therapy in ambulatory settings.

Common application scenarios include hospital wards, emergency departments, and outpatient infusion centers.

Best Practices for Use and Maintenance

  • Storage: Store in a cool, dry location away from direct sunlight.
  • Inspection: Always check the packaging for integrity and expiration date before use.
  • Handling: Use aseptic techniques during preparation and administration to minimize contamination risks.
  • Disposal: Dispose of the container responsibly after single use, following institutional and local waste management guidelines.

Regulatory and Safety Information

The product adheres to:

  • FDA and USP Standards: Ensuring compliance with rigorous quality and efficacy requirements.
  • ISO Certification: Guaranteeing consistent performance and reliability in healthcare settings.

These certifications provide healthcare professionals with confidence in its use for safe and effective bacterial infection treatment.

How to Order

To purchase the B Braun 3125-11 - Cefoxitin for Injection USP 2g with Dextrose Injection, 50mL:

  • Select the desired quantity on the product page and proceed to checkout.
  • For bulk orders or additional inquiries, contact CIA Medical customer service at (312) 275-5850 or use the contact form available on the website.
Related Products